相关实验视频

Updated: Jul 5, 2025

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

瑞诺丁受体功能障碍导致杜申尼扩大心肌病的衰老和纤维化

Monia Souidi¹, Jessica Resta², Haikel Dridi³

¹PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.

Journal of cachexia, sarcopenia and muscle

|January 14, 2024

概括

杜氏肌肉发育不良 (DMD) 通过异常的处理导致早期心脏损伤. 准RyR2通道可以预防纤维化和衰老,为DMD相关的扩张性心肌病 (DCM) 提供潜在的治疗方法.

科学领域:

心血管研究研究心血管研究
遗传学和分子生物学
细胞生物学细胞生物学

背景情况:

杜氏肌肉发育不良 (DMD) 是一种X关联疾病,导致渐进性肌肉衰弱和扩张性心肌病 (DCM).
DMD涉及异常的细胞内 (Ca2+) 循环,与sarcoplasmic网膜 (SR) 赖诺丁受体2 (RyR2) 重塑有关,有助于DCM.
之前对mdx小鼠和GRMD狗的研究表明,年龄依赖的DCM与RyR2功能障碍有关.

研究的目的:

通过使用患者衍生细胞和动物模型,研究早期的杜氏DCM特征.
评估RyR2在DMD相关心脏病理学中的作用.
评估RyR2稳定疗法的治疗潜力.

主要方法:

利用来自DMD患者的诱导多能干细胞衍生心肌细胞 (hiPSC-CMs).
从犬类DMD模型 (GRMD) 中分析了心脏活检.
评估了RyR2功能,SR Ca2+泄漏,衰老标志物,纤维化和收缩性.
研究了药理 RyR2 稳定 (S107) 的作用.

主要成果:

与RyR2重塑和增加SR Ca2+泄漏在DMD hiPSC-CMs和GRMD心脏中相关的双素缺乏.
在DMD细胞中,老化标志物 (p15,p16) 和纤维化增加.
在DMD hiPSC-CMs中观察到心脏缺约性.
药理稳定RyR2与S107改善了病理特征,包括恢复收缩幅度.

结论:

关键的细胞损伤,包括纤维化和过早衰老,在DMD中比临床心脏病理更早发生.
RyR2介导的SR Ca2+泄漏是DMD早期心脏损伤的主要驱动因素.
RyR2 作为DMD相关心脏损伤的早期生物标志物.
准RyR2通道为DMD诱导的DCM提供了一个有希望的治疗策略.

关键词:

是一种在 DMD DMD 里面,你会发现瑞亚诺丁受体的受体衰老是一种衰老.由hiPSC衍生的心肌细胞.

更多相关视频

Organotypic Retinal Explant Cultures from Macaque Monkey

Organotypic Retinal Explant Cultures from Macaque Monkey

Published on: August 24, 2022

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...